09.02.2016
- Martin Shkreli, the 32-year-old former CEO of Turing Pharmaceuticals who made negative headlines last year after jacking up the price of the toxmoplasmosis drug Daraprim...
28.01.2016
- The pharmaceutical industry has often been accused of trying to keep affordable generic drugs off the market, with the addition – for example – of new indications or product...
